The platform, an extension of the Faculty Frontier decision intelligence suite, provides engineers with a unified layer to configure, test, and validate simulations. Current clinical development often suffers from siloed tools and manual processes, which frequently lead to delayed timelines and limited visibility across global trial sites. The new studio replaces these fragmented approaches by allowing teams to reconcile simulations with real-world clinical data more effectively.

A key feature of the release is the inclusion of embedded AI agents tasked with debugging and validation. These agents monitor data streams—ranging from patient enrollment events to site activation logs—to automatically identify discrepancies and suggest real-time fixes. This automation reduces the technical overhead required to maintain complex models as trial conditions evolve. The studio is now available to all existing Frontier customers, providing a scalable foundation for deploying decision intelligence across diverse therapeutic areas and geographic regions.